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Zika virus (ZIKV) infection during pregnancy is associated with microcephaly, a congenital
malformation resulting from neuroinflammation and direct effects of virus replication
on the developing central nervous system (CNS). However, the exact changes in the
affected CNS remain unknown. Here, we show by transcriptome analysis (at 48 h
post-infection) and multiplex immune profiling that human induced-neuroprogenitor stem
cells (hiNPCs) respond to ZIKV infection with a strong induction of type-I interferons
(IFNs) and several type-I IFNs stimulated genes (ISGs), notably cytokines and the
pro-apoptotic chemokines CXCL9 and CXCL10. By comparing the inflammatory profile
induced by a ZIKV Brazilian strain with an ancestral strain isolated from Cambodia in
2010, we observed that the response magnitude differs among them. Compared to
ZIKV/Cambodia, the experimental infection of hiNPCs with ZIKV/Brazil resulted in a
diminished induction of ISGs and lower induction of several cytokines (IFN-α, IL-1α/β,
IL-6, IL-8, and IL-15), consequently favoring virus replication. From ZIKV-confirmed infant
microcephaly cases, we detected a similar profile characterized by the presence of IFN-α,
CXCL10, and CXCL9 in cerebrospinal fluid (CSF) samples collected after birth, evidencing
a sustained CNS inflammation. Altogether, our data suggest that the CNSmay be directly
affected due to an unbalanced and chronic local inflammatory response, elicited by ZIKV
infection, which contributes to damage to the fetal brain.
Keywords: Zika virus, central nervous system, inflammation, type-I interferon, interferonopathy, microcephaly,
Zika congenital syndrome and cytokines
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INTRODUCTION
Congenital Zika Syndrome (CZS) comprise a wide spectrum
of birth defects and symptoms observed in infants who
have been exposed to Zika virus (ZIKV) during embryonic
development (1). Although other minor abnormalities have been
documented, the most dramatic symptoms are microcephaly,
severe microcephaly, arthrogryposis, and ocular damage
(2). Microcephaly is characterized as a developmental brain
malformation that results in a cranial circumference <2
standard deviations (2-SD) below the average for the same sex
and gestational age, on the same way, severe microcephaly is
classified based on a cranial circumference <3-SD below the
average (3, 4). Microcephaly associated with ZIKV infection in
pregnancy was first reported in Brazil in 2015 during a large
outbreak of this virus (5). Initial associations between ZIKV
infection and microcephaly development were based on the
identification of viral RNA in fetal amniotic fluid (6) and in the
brain tissue of fetuses and infants diagnosed with microcephaly
(7, 8). Later, several reports from independent groups confirmed
the association between ZIKV infection during pregnancy and
congenital abnormalities (9).
Diagnosis of CZS is complex and involves several different
steps, including taking head circumference measurements,
neurological evaluation, radiologic brain imaging and
ophthalmologic assessment. ZIKV exposure confirmation
can be accomplished using molecular and serologic standard
methods. However, since ZIKV is present in body fluids with
different shedding kinetics, confirmation of virus infection
remains challenging (10). In neonates presenting with signs
of microcephaly, ZIKV infection can be confirmed by virus
detection (i.e., RT-PCR) or by the presence of ZIKV-specific IgM
in cerebrospinal fluid (CSF) or serum (4, 11). Importantly, the
presence of anti-ZIKV IgM in the CSF of neonates with suspected
CZS is a strong indicator of a recent congenital infection (12).
Although significant improvements have been reached in
terms of diagnosis, the exact pathogenic mechanisms related
to ZIKV-induced microcephaly and others malformations
remain largely unknown. Emerging evidence demonstrated
that ZIKV infection impairs brain development by arresting
cellular neurogenesis, leading to the deregulation of cell-cycle
progression and apoptosis (13–16). Moreover, previous work has
also assessed the birth defects resulting from ZIKV exposure in
different pregnant mouse models (17–20). While most studies
are focused on elucidating the specific cellular mechanisms
of ZIKV pathogenesis through in vitro or in vivo models, the
pathogenesis among naturally infected human subjects and
its biological implications have not been investigated to the
same extent.
In humans, the central nervous system (CNS) becomes to
be established from 22 days onwards. Initially, the embryonic
brain is entirely composed of highly proliferative neuronal
progenitor cells (NPCs). Thus, at this stage, pathogenic processes
induced by the unbalanced production and local secretion of
immunoregulatory molecules may lead to reduced brain size, and
consequently microcephaly (21). Therefore, investigations into
ZIKV triggered immune responses, especially in the CNS, may
contribute to a better understanding of the disease mechanisms
since specific immune mediators may play a major role in
the pathogenesis of microcephaly. The finding that ZIKV
infection leads to apoptosis in different neuronal models could
also partially explain the cellular destruction observed in the
radiological examination of neonates with CZS (22). On the other
hand, the paracrine effects of cytokines and chemokines directly
secreted in the CNS by the infected cells are still unknown. More
recently, Tappe et al. (23) assessed cytokine kinetics in the serum
of ZIKV infected patients. Despite the relatively small number
of patients analyzed, the authors were able to compare samples
from the acute and convalescent-phase, observing elevated levels
of the chemokines CCL3, CCL4, CCL5 and CXCL10 during the
recovery phase. During the acute phase, the authors observed a
mixed cytokine pattern, with the increase of cytokines profiles
associated with Th1, Th2, Th17, and Th9 CD4+ T cell responses
(23). In addition, it was reported that there were increased
levels of CXCL10 and CCL2, IL-6, IL-8, VEGF, and G-CSF
in the amniotic fluid of ZIKV-positive pregnant women with
neonatal microcephaly (24). Furthermore, the overexpression of
CXCL10 was recently identified as a potential serum biomarker
of acute ZIKV infection (25). Taken together, these findings
may suggest that ZIKV infection results in a specific pro-
inflammatory profile. However, no reports from microcephaly
cases were available so far, and it remains to be elucidated
whether ZIKV-inducedmicrocephaly could be associated with an
organ-specific inflammation.
Here, we analyzed the transcriptional changes induced by
ZIKV infection in human induced pluripotent neuroprogenitor
stem cells (hiNPCs). We used this model to compare the
pathogenesis of a contemporary South American strain
(isolated in Brazil in 2015 at the peak of microcephaly
cases) vs. an ancestral Asian strain isolated in Cambodia in
2010. Transcriptional data were further confirmed at protein
expression levels and by assessing the levels of cytokines
and chemokines in the CNS of confirmed ZIKV-induced
microcephaly cases and validated through a second in vitro
infection assay in human neuroblastoma cells. Our findings
suggest an important role of type-I interferon (IFN) response
and chemokines CXCL10 and CXCL9 in the pathogenesis of
microcephaly, which may represent a still unaddressed target
with the potential to interrupt the destructive CNS inflammation
induced by ZIKV infection.
METHODS
hiNPCs Culture and Infection
Human induced neuroprogenitor cells (hiNPCs) derived
from human induced pluripotent stem cells (hiPSCs), line
73-56010-02 sub-clone F, were grown on matrigel-coated,
cell culture treated plates. Briefly, hiPSCs, were cultured with
neuronal precursor selection medium, followed by neuronal
precursor expansionmedium (Thermo Fisher Scientific, Munich,
Germany) containing fibroblast growth factor 2 (R&D Systems,
Minnesota, USA) for the generation of neural stem cells. After
5–7 days in culture, neural rosettes were identified, manually
dissected and plated into low-attachment plates where embryoid
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body-like structures—denoted as neurospheres—emerged.
Following the plating of neurospheres into the matrigel-coated
plates, hiNPCs were collected manually for monolayer culture.
hiNPCs were then cultured in neurobasal medium containing
B27 (Thermo Fisher Scientific, Munich, Germany) supplement
and brain-derived neurotrophic factor 10 ng/mL (R&D Systems,
Minnesota, USA) for neuronal differentiation. hiNPSCs cultured
cells, passage 5, were grown until 85% confluent in 12-well plates
and further infected at (multiplicity of infection) MOI 1 with
a ZIKV Brazilian strain (ZIKV/H.sapiens/Brazil/PE243/2015,
GenBank: KX197192.1), previously described (26) or a ZIKV
Cambodian strain (Zika virus isolate Cambodia FSS13025/2010,
GenBank: JN860885.1) prepared in Vero E6 cells, previously
established in our laboratory. At 1-h post infection, the
inoculation medium was removed and replaced with culture
medium. At 48 h post infection, the cells were harvested
and RNA was extracted for RNA-sequencing (RNA-Seq) and
transcriptomic analysis.
RNA-Seq and Data Analysis
RNA-Seq was performed at the Genomics Research Core,
University of Pittsburgh, USA. Before sequencing, RNA quality
was checked using the Agilent High Sensitivity RNA ScreenTape
System (Agilent Technologies, Santa Clara, USA). Whole-
transcriptome sequencing was performed using the TruSeq
Stranded Total RNA kit (Illumina Inc., San Diego, CA, USA)
with an average of 49.1 million reads per library. Each condition
(infected and control samples) was sequenced in triplicate. The
quality of sequenced reads was assessed by FastQC tool. Reads
from each library were mapped against the human genome
assembly GRCh38 with the annotation version 91 downloaded
from the Ensembl database, applying the STAR aligner version
2.5.3. Later, R package DESeq2 was used to perform differential
expression analysis (DEA). During this step, the biological
replicates from infected and control samples were compared, but
only genes presenting at least ten reads for all three biological
replicates in at least one condition were considered for DEA.
Genes with an absolute value of log2 fold change equal to or
>1 and with a p-value, correct by the FDR approach, of <0.05
were selected for functional analysis using the STRINGdb
R package (http://www.string-db.org) and KEGG REST for
pathway-based data integration (https://www.kegg.jp/kegg/
rest/). The former was used to assign Gene Ontology (GO)
(http://geneontology.org/) and Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathway terms to differentially expressed
genes (DEGs). In addition, the Biological Process ontology of
GO was employed to perform a functional enrichment analysis
for those genes. KEGG pathways were grouped into four
categories (adaptive immune response, cytokine and chemokine
signaling, interferon response, and cell death and growth) to
visualize protein networks present in the STRING database. The
protein networks built from the lists of DEGs were analyzed
using Cytoscape software, version 3.6.0 (https://cytoscape.org/).
Heatmaps were built using the gene counts normalized by the
library size factors using the function heatmap of R environment.
The mean of gene expression fold change from infected cell
samples were plotted vs. the expression found in non-infected
ones (Control) and visualized with ViaComplex software (27)
(http://lief.if.ufrgs.br/pub/biosoftwares/viacomplex). For this
analysis, we selected only the list of modulated genes identified
in Figure 2A.
Infection of Neuroblastoma Cells and
Cytokine Analysis
Human undifferentiated neuroblastoma cells (cell line SH-SY5Y-
ATCC R© CRL-2266TM) was cultured in 1:1 MEM and Ham’s F12
Nutrient Mixture, supplemented with 1mM sodium pyruvate,
2 mmol/L L-Glutamine, non-essential amino acids, 100 U/mL
penicillin, 100µg/mL streptomycin (Thermo Fisher Scientific)
and 10% (v/v) fetal bovine serum in a humidified incubator
at 37◦C with 5% CO2. Cells were infected with ZIKV/Brazil
(ZIKV/H.sapiens/Brazil/PE243/2015, GenBank: KX197192.1) and
analyzed at different days post-infection (dpi), as described
on figure legends. Briefly, cells were harvested at 2 dpi
and stained with anti-flavivirus envelope (E) protein primary
antibody (4G2) and goat anti-mouse IgG secondary antibody
conjugated with FITC (Sigma-Aldrich, St. Louis MO), and
analyzed by flow cytometry (FACS). Supernatants were harvested
and processed for viral RNA extraction and qRT-PCR assays
in several time points post-infection. In addition, supernatants
were also harvested at 3 dpi and soluble cytokines and
chemokines were quantified by the kit Cytometric Bead Array
(CBA) Human Inflammatory Cytokine and Human Chemokine
Kit (BD Biosciences, San Diego, CA, USA), following the
manufacturer’s instructions.
Patients
Cases of microcephaly and other birth defects enclosing the CZS
cases notified from 2015 to 2017 were investigated following
a previously established protocol from the Brazilian Ministry
of Health as follows: neonates with suspected microcephaly
were investigated by measuring their head circumference. Those
with a circumference of at least 2 SD below the mean for
the same sex and gestational age on the Fenton growth
chart were diagnosed with microcephaly. Severe microcephaly
was diagnosed in those infants who presented with a head
circumference smaller than 3 SD. Brain imaging was performed
whenever possible. Control subjects were live neonates with
suspected microcephaly at birth who had a CSF sample collected
to perform ZIKV diagnosis, which were later classified as
healthy through transfontanellar ultrasonography of the brain
and which presented no other major birth defects. Exclusion
criteria were anencephaly, encephalocele, and the confirmation of
the phenotype of a well-defined congenital syndrome. Congenital
infections, other than ZIKV, were assessed in infants andmothers
from a blood sample collected right after birth by the STORCH
laboratory-testing panel (congenital infections encompassing
syphilis, toxoplasmosis, rubella, cytomegalovirus and herpes
simplex virus). CSF samples from all neonate CZS suspected
cases were collected by lumbar puncture, samples collected
at a maximum of 4 weeks after birth were included in this
study. For ZIKV infection confirmation, CSF samples were
forwarded to the Arbovirus Reference Laboratory at the Oswaldo
Cruz Foundation, Fiocruz/Recife, Brazil. ZIKV infection was
diagnosed by detection of IgM antibodies or by ZIKV RNA
presence determined by Real Time RT-PCR (rRT-PCR). ZIKV
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exposure was confirmed based on a positive laboratory result
from CSF and/or serum.
Multiplex Immunoassays
Individual cytokines in all human neonate CSF samples were
assayed in a Luminex Platform employing a commercially
available kit: Cytokine Human Magnetic 25-Plex Panel
(Thermo Fisher Scientific, Munich, Germany) following
the manufacturer’s instructions. hiNPC-derived infected
supernatants were virus-inactivated by homogenizing samples
in NP-40 at 0.2% and analyzed by the Human Cytokine 42-
Plex Discovery Assay (Eve Technologies, Calgary, Canada).
A complete list of the analyzed cytokines and chemokines
and its detection limits are described in Supplementary
Material (Tables S2, S3).
Ethics Statement
Ethics protocol and procedures have been reviewed and approved
by Institutional Ethics and Research Committee of the Institute
Aggeu Magalhaes, Oswaldo Cruz Foundation–Fiocruz, Brazil
(CAAE: 73669417.7.0000.5190). The hiNPC-based studies were
approved by the University of Pittsburgh internal IRB and IBC.
ZIKV ELISA IgM
ZIKV IgM antibodies were detected by MAC-ELISA (Capture
Enzyme-Linked Immunosorbent Assay), employing an in-house
protocol. Briefly, ZIKV antigen was prepared from ZIKV-
infected Vero E6 cells. ELISA plates were sensitized with
Goat anti-human-IgM (KPL/Sera Care, Milford, USA), before
samples were added (1/400 dilution). Reactions were performed
employing a detection antibody (MAB 6B6C-1/HRP), kindly
provided by CDC (Centers for Disease Control and Prevention,
Atlanta, USA). Serum and CSF samples were considered positive
when the optical density exceeded 3.0 times that of the
negative control.
Virus Detection–Real-Time RT-PCR and
Plaque Assays
Viral RNA was extracted manually from human serum and
CSF samples using a QIAamp Viral RNA kit (Qiagen, Hilden,
Germany), following the manufacturer’s instructions. ZIKV
Real Time RT-PCR (rRT-PCR) reactions were performed from
purified RNA serum samples employing primers and probes
as described by Lanciotti et al. (28). Briefly, reactions were
performed in duplicate in a final volume of 20 µl employing
the kit GoTaq R© Probe 1-Step RT-qPCR (Promega Corporation,
Madison, USA), following manufacturer instructions. Cycling
was performed using the QuantStudio 5 Real-Time system
(Thermo Fisher Scientific) and samples with a Ct value <38 in
duplicate wells were considered to be positive for ZIKV. For
quantitative Real Time RT-PCR assays (RT-qPCR) a standard
curve for ZIKV RNA copies was prepared from a previously
titrated virus stock (range 101 to 106 PFU/mL). Plaque assays
were performed on Vero E6 cells. Briefly, cells were seeded
at a density of 3 × 105 cells per well in standard 24
well plates and infected with serial dilutions of either cell
culture supernatant from infected hiNPCs or virus stocks (for
virus titration assays). After 2 h at 37◦C the inoculum was
removed and the cells were washed with PBS. Then the cellular
monolayers were overlaid with DMEM2% containing 1.5%CMC
(carboxymethyl cellulose). Five to seven days later, the wells
were washed with PBS. Afterwards, the cells were fixed with 4%
formaldehyde for 10min and stained with 0.1% crystal violet for
plaque visualization.
Statistical Analysis
The Mann-Whitney unpaired test was used to compare
continuous variables. Results were expressed as Tukey box-
and-whisker plots showing median, upper and lower quartile,
minimum, and maximum values. Outliers are represented by
dots outside the 1.5 interquartile range of the 25 respective 75
percentile. All p-values were two sided with a significance level
of 0.05. Calculations were performed using GraphPad Prism 7
software. Cytokines and chemokines data are represented by
mean ± SD. Statistical analysis was performed by unpaired
Student’s t-test using the GraphPad 7 software.
RESULTS
Transcriptional Changes in ZIKV-Infected
hiNPCs
To identify the transcriptional profile that may account for
the differentially activated host response during infection with
a contemporary vs. an ancestral ZIKV Asian strain, here
denominated ZIKV/Brazil and ZIKV/Cambodia, respectively,
hiNPCs were infected, and after 48 h total RNAwas extracted and
analyzed using the Illumina NextSeq 550 sequencing platform.
Figure 1A shows the global expression changes, represented
by normalized RNA-Seq read counts among all the transcripts
identified as significantly changed, only if the fold change
(log2) was >2 (up or down) and the corrected P-value was
less or equal than 0.05, in comparison to the control group.
Overall, of all the identified genes, both strains induced profound
transcriptional modifications. Thus, to better classify those genes
that may account for the different immune response induced
by both strains, we categorized these identified transcripts
according to KEGG pathways. The clusters of differentially
expressed genes that were either up or downregulated included
several key cellular processes that were related to adaptive
immune response, cytokine and chemokine signaling, interferon
response, and cell death and growth (Figures 1B–E). Among the
modulation on genes induced by both strains, we identified the
upregulation of innate immune regulatory molecules, including
several C-X-C motif chemokines, STAT genes, MAPK pathway,
as well as transcripts for TLR3, IRF7, and other type-I IFN
pathway-related genes. Adaptive immune response genes were
also upregulated (Figure 1B). Comparative analysis of the
transcriptional signature of infected hiNPCs demonstrated that
ZIKV/Cambodia infection resulted in a higher modulation of
specific gene clusters, including several C-X-C motif chemokines
and type-I IFN response genes (Figures 1C,D). On the other
hand, ZIKV/Brazil induced a more pronounced modulation of
cell death and cell growth-related genes (Figure 1E).
Predictive network analysis suggested that a significant
portion of the differentially up-regulated genes comprehends
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FIGURE 1 | Transcriptional changes in hiNPCs induced by ZIKV infection. (A) Hierarchical clustering and heatmap of genes that are differentially expressed between
non-infected control, ZIKV/Brazil and ZIKV/Cambodia infected hiNPCs. (B–E) Hierarchical clustering of heatmaps presented as normalized read-counts and
(Continued)
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FIGURE 1 | represented according to different groups of KEGG analyzed pathways. (B) Adaptive immune response. (C) Cytokine and chemokine signaling.
(D) Interferon response. (E) Cell death and growth. Heatmaps are representative of all identified expressed transcripts, scale bar represents gene expression of
normalized reads counts for each individual triplicate. Color gradient ranges from blue (low RNA-Seq read counts) to red (high RNA-Seq read counts). Single panel
lines are representative of individual infection experiments as stated for ZIKV/Brazil, ZIKV/Cambodia and control group (n = 3). Also see Figures S2–S4, which
represent STRING functional protein networks analysis for the genes represented in the heatmaps.
FIGURE 2 | ZIKV-dependent specific cellular processes induced in hiNPCs. (A) Specific networks induced by ZIKV/Brazil (right) and ZIKV/Cambodia (left) infected
hiNPCs. Selected modules from the protein-protein interaction network were grouped according to KEGG pathways. Color gradient ranges from blue (down-regulated
in infected cells) to red (up-regulated in infected cells), and it represents the mean fold change (log10) in expression levels relative to control (non- infected cells).
(B) Gene network (from protein-protein interaction network) represented by a three-dimensional network topology view evidencing a strong upregulation of the
interferon response in ZIKV/Brazil infected hiNPCs. (C) Gene network (from protein-protein interaction network) represented by a three-dimensional network topology
view evidencing a strong upregulation of the interferon response in ZIKV/Cambodia infected hiNPCs. Color gradient represents the transcriptional activity of infected
cells from blue (low activity) to red (high activity). (D) Gene Ontology (GO) enrichment analysis in “Biological Process” category statistically overrepresented among all
differentially expressed genes. GO terms were represented by 2-fold enrichment value, with p-values <0.05. Infection experiments and control groups were performed
in triplicate (n = 3).
a set of common pathways (Figure 2A and Figures S1–S4).
Overall, the majority of genes that displayed a significant
difference between control and infected cells were upregulated
(Figure 2D). With regards to downregulated pathways, we
observed changes mostly in genes related to metabolism and
neurotransmitters (Figure 2D). Among all these processes there
was a highly up-regulated notable gene cluster, the type-I
IFN response. This cluster includes transcripts for IFNB1,
STAT1, IRF3, IFNAR2, IRF7, and TLR3 (Figures 1D, 2D). Other
transcripts were also detected at increased levels, including
chemokine transcripts CXCL9, CXCL10 (among the top-ranked
expressed genes), CXCL1, and CCL5. The network of highly
modulated genes was further analyzed with the ViaComplex
software, which compared the transcriptional profile of infected
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FIGURE 3 | Induction of cytokine and chemokine production by ZIKV infection in hiNPCs. Individual cytokine and chemokine levels (as indicated on figures) were
measured in hiNPCs cell-free supernatants from mock (non-infected), ZIKV/Brazil and ZIKV/Cambodia at 72 h post infection. Data indicate mean and SD of
experiments performed in triplicate (n = 3), values are represented in picograms per milliliter (pg/mL). Groups were compared using non-parametric One-Way ANOVA.
*P < 0.05, **p < 0.01, ***P < 0.001, ****P < 0.0001, NS, non-significant.
vs. uninfected cells plotting the mean expression values (Z-axis)
as a 3D landscape topographical view, this analysis showed
the cluster of type-I IFN response as the highest level of
expression induced by infection (Figures 2B,C). In general,
both strains were able to upregulate the type-I IFN response,
however, we found that ZIKV/Cambodia induced a more
robust modulation. Together, these results suggest that the
ZIKV induced transcriptional changes are, at least in part,
strain dependent.
To confirm this inflammatory transcriptional profile we
quantified the concentration of cytokines, chemokines and
growth factors in hiNPCs supernatants through a multiplex
assay, which included several soluble markers. We compared
the levels of these markers induced after infection by both
strains in a single time point (72 hpi). We observed a strong
significant modulation of the pro-inflammatory cytokines IL-
1α/β, IL-6, and IL-8, and the chemokines CCL5, CXCL10,
and CXCL1, induced by both strains. ZIKV/Cambodia induced
significantly higher levels of IFN-α2, compared to ZIKV/Brazil
infected hiNPCs. Also, ZIKV/Cambodia infection was associated
with significantly enhanced levels of CXCL10, CCL5, CCL11
and the pro-inflammatory cytokines IL-6, IL-8, IL-15, IL-12p40,
and IL-1α/β (Figure 3). Overall, inflammatory markers assessed
by this analysis correlated with the transcriptional profiles in
infected hiNPCs.
To further explore if the enhanced inflammatory activity
from ZIKV/Cambodia infected cells was associated with a
difference in virus replication, we quantified the average reads
depth of the ZIKV genome from infected and non-infected
hiNPCs. As expected, no ZIKV genome reads were observed
in the control group (Figure 4A). However, nearly complete
ZIKV genomes were recovered from infected hiNPCS, with
a high coverage from both strains (coverage above 99.9%).
NGS results demonstrated that ZIKV/Cambodia gave a much
lower read counts average (depth below 10,000) compared to
ZIKV/Brazil infected cells (depth above 10,000) (Figures 4B,C).
Albeit lower, ZIKV/Cambodia sequencing depth RNA levels,
were not correlated to a significant increased viral load
(infectious particles) in infected hiNPCs supernatants, analyzed
at 48 hpi (Figure 4D). Thus, despite the minor differences in
Frontiers in Immunology | www.frontiersin.org 7 August 2019 | Volume 10 | Article 1928
Lima et al. Immune Profiles of Zika Microcephaly
virus replication, it is suggestive that the magnitude of the
inflammatory response may interfere with the viral titers, though
key pathways are activated regardless of the virus strain.
ZIKV Infection of Human Neuroblastoma
Cells Also Induce Chemokines Release
Given the ability of ZIKV infection to up-regulate chemokines
and cytokines transcripts in hiNPCs, we determined the
susceptibility of a distinct neuronal cell line. For this, we
opted to evaluate the feasibility of human neuroblastoma cells
(SH-SY5Y cells) to respond to ZIKV infection by increasing
cytokines/chemokines production. First, to confirm infection,
undifferentiated SH-SY5Y cells were infected and analyzed by
FACS at 2 dpi, positive viral envelope protein (E) staining
was observed in a large percentage (65.1%) of the infected
cells (Figure 5A) and viral RNA, detected in the supernatant,
increased over time (Figure 5B), confirming that these cells
were susceptible to infection. Next, we evaluated the presence
of a set of cytokines and chemokines in the supernatants using
two different sets of human CBA assays. The results show
increased production of IL-8, CXCL10, CCL2, CCL5, and IL-6
(Figure 5C) at 3 dpi, indicating the ability to induce an active
pro-inflammatory response. No other cytokines were detected
at significantly increased levels (data not shown). Infection also
results in enhanced expression of several IFN stimulated genes,
especially IFNA1, IFNB1, and TLR3 transcripts (Figure 5D).
CNS Inflammatory Profile of ZIKV
Confirmed Microcephaly Cases
The increased type-I IFN and chemokine responses observed
from ZIKV infection are common features of viral infections
including ZIKV, however, in the CNS, a hyperactivation or
a sustained inflammatory process may result in extensive
tissue damage, especially in the context of a developing brain.
Thus, to better characterize the ZIKV inflammatory profile
we assessed the CNS immune profile of confirmed ZIKV-
induced microcephaly and severe microcephaly human cases
(here, collectively denominated “microcephaly”). From a total
2,334 CZS suspected cases from September 2015 to May
2016 in Northeastern Brazil, we were able to identify 27
healthy control patients (no brain alterations) and 51 cases
of microcephaly, based on clinical diagnosis, with CSF sample
availability (characterized by a previous collected sample stored
at the laboratory). Among the microcephaly cases included in
our study, 40 (78.4%) were diagnosed as severe microcephaly
(head circumference <3 SD on the Fenton growth chart) and
11 as microcephaly (head circumference <2 SD). Complete
information and patient characteristics and laboratory results
are summarized in Table 1. Additional laboratory data are
summarized in Table S1 and Supplementary Material. ZIKV
infection was diagnosed by the presence of anti-ZIKV IgM
in the CSF in all of the 51 confirmed microcephaly cases.
Among these 51 cases, the presence of ZIKV RNA (rRT-PCR)
was identified in only two samples (Table S1). Importantly,
no positive anti-ZIKV IgM or rRT-PCR CSF samples were
observed in the healthy control group. STORCH testing for
TABLE 1 | Characteristics of patients included in the study.
Healthy control Microcephaly
Neonates, total number of subjects (%) 27 subjects 51 patients
Male 10 (37) 22 (43)
Female 17 (63) 29 (57)
Gestational age at birth, (%)
Pre-term 5 (18.5) 5 (9.8)
Term 21 (77.8) 44 (86.2)
Post-term 1 (3.7) 2 (4)
Birth weight, grams (%)
>2,500 g 19 (70.4) 39 (76.5)
>1,500–2,499.9 g 8 (29.6) 10 (19.6)
<1,500 g 0 1 (1.95)
Not informed 0 1 (1.95)
Head circumference (%)
Normal 27 (100) 0
<2 SD (microcephaly) 0 11 (21.6)
<3 SD (severe microcephaly) 0 40 (78.4)
Mothers (total number of subjects) 27 51
Reported rash during pregnancy (%)
No rash 26 (96.3) 35 (68.6)
First trimester 0 9 (17.6)
Second trimester 1 (3.7) 1 (1.95)
Third trimester 0 3 (5.9)
Yes, unknown period 0 3 (5.9)
A total of 27 neonates with a discarded diagnosis of microcephaly (healthy controls)
were included in this study. Among the confirmed microcephaly and severe microcephaly
cases, a total of 51 neonates, which had CSF samples available, were included for further
cytokine investigation. All of the neonates had CSF samples collected no later than 4
weeks after birth.
common congenital infections was performed for all subjects,
and no IgM reactive samples were documented (Table S1
and Supplementary Material). Based on this, other congenital
common infections were ruled out, and the final diagnosis was
microcephaly associated with maternal ZIKV infection.
CSF samples from healthy control subjects and microcephaly
neonate cases were analyzed employing a panel of 25 different
human cytokines and chemokines. Through our analysis,
microcephaly-associated CSF samples showed significantly
higher levels of IFN-α (p = 0.0428), compared to the control
group. Albeit slightly higher, there was no significant difference
in the levels of IL-1β and IL-1RA (p = 0.054 and p = 0.10,
respectively). The pro-inflammatory cytokines IFN-γ, IL-6, and
IL-8 were similar between the groups. Among chemokines, we
did not observe a significant difference in the levels of CCL2,
CCL3, CCL4, CCL5, and CCL11. Interestingly, consistent with
the in vitro results, two CXC chemokine ligands were found at
significantly higher levels in the CSF samples from microcephaly
cases: CXCL9 and CXCL10 (p = 0.028, and p = 0.0003,
respectively). Among T-cell activation related cytokines, we did
not observe a cytokine signature associated with a predominant
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FIGURE 4 | ZIKV replication in hiNPCs. Sequencing results of the infected hiNPCs were mapped to the reference genome of Zika virus (x-axis). The depth of coverage
achieved from infected hiNPCs cultures and mock (non-infected control cultures) was calculated for each condition as the total number of reads (average depth),
mapped against a reference genome. ZIKV/Brazil infected hiNPCs reads were mapped against the reference genome: ZIKV/Brazil/PE243/2015 (GenBank:
KX197192), ZIKV/Cambodia infected hiNPCs were mapped against the reference genome ZIKV/Cambodia/FSS13025/2010 (GenBank: JN860885.11).
(A) Mock–non-infected cells. (B) hiNPCs infected with ZIKV/Brazil, analyzed at 48 h post infection. (C) hiNPCs infected with ZIKV/Cambodia, analyzed at 48 h post
infection. (D) hiNPCs were infected in triplicate (n = 3) with either ZIKV/Brazil or ZIKV/Cambodia at a multiplicity of infection of 0.1. Infectious virus recovery in
supernatant at 48 h post infection was determined by plaque titration assay. Values are expressed as mean of plaque forming units per milliliter (PFU/mL). Bars are
representative of individual infection experiments performed in triplicate (n = 3).
FIGURE 5 | ZIKV infection of human neuroblastoma cells results in cytokine release. (A) SH-SY5Y cells were infected with ZIKV/Brazil (MOI = 1), harvested at 2 days
post-infection (dpi), stained with anti-flavivirus envelope (E) protein 4G2 and anti-mouse conjugated with FITC, and analyzed by flow cytometry (FACS). (B) SH-SY5Y
cells were infected with ZIKV/Brazil (MOI = 1) and the supernatants were processed for viral RNA extraction and qRT-PCR at different days post infection.
(C) SH-SY5Y cells were infected with ZIKV/Brazil (MOI = 0.5), supernatants were harvested at 3 dpi and cytokines/chemokines production levels were quantified by
Cytometric Bead Array. (D) RT-qPCR results of selected genes related to type-I IFN response. Relative expression (fold change) of mRNA transcripts are shown from
infected SH-SY5Y cells (analyzed at 48 h after infection) relative to control group. Mock—cell not infected. Data are represented by mean ± SD. Figures are
representative of three independent experiments, performed in triplicate (n = 3). *p < 0.05, **p < 0.01, by unpaired Student’s t-test.
helper T-cell response. We also observed no difference in
IL-5, IL-10, IL-13, IL-15, IL-17, and interleukin-2 receptor
(IL-2R) production between microcephaly cases compared to
the control group (Figure 6). Four cytokines (GM-CSF, TNF-α,
IL-2, and IL-4) were below the detection limit (data not shown).
Altogether, these observations show that the transcriptional
changes induced by ZIKV infection results in respective protein
levels increase in vitro and that this inflammatory signature
is also present in the CNS of ZIKV-induced microcephaly
cases. Moreover, our data suggest that children suffering
from ZIKV-induced microcephaly may experience long-term or
chronic neuroinflammation.
DISCUSSION
Currently, the underlying pathophysiological mechanisms
of ZIKV-induced microcephaly and CZS remain poorly
understood. It has been documented that ZIKV infection
leads to a reduction in NPCs numbers as a result of apoptosis
(29), cell cycle arrest (30), and premature differentiation (31),
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FIGURE 6 | Cytokine and chemokine profiles in the CSF of control and microcephaly cases. Individual cytokine and chemokine levels (as indicated on figures) were
measured in the CSF of control (n = 27) and ZIKV-induced microcephaly cases (n = 51), and are represented by Tukey box-and-whisker plots showing median, upper
and lower quartile, minimum, and maximum values (picograms per milliliter-pg/mL). Outliers are represented by dots outside the 1.5 interquartile range of the 25
respective 75 percentile. Mean values are indicated by a plus (+) sign. Mann-Whitney unpaired test *P < 0.05, ***P < 0.001, vs. healthy control (exact p-values are
described in figures). NS, non-significant vs. healthy control.
consequently impairing neuronal development. Although NPCs
are the main targets of ZIKV replication effects, infection in
isolated cell models are frequently underexplored regarding
inflammatory responses (32). Here, we employed different
approaches to better characterize the CNS inflammatory
response induced by ZIKV infection. First, through the use
of hiNPCs, we observed a strain-dependent modulation of
host genes, including the induction of several ISGs. Next, we
confirmed that experimental infection of hiNPCs leads to
extensive chemokine and cytokine release, consistent with the
induced transcriptional profile. Since the manipulation of stem
cells may result in differentiation variability between distinct
cell lines, laboratories and in variations in differentiation
efficiency (33), we opted to include a second cell line
to model ZIKV infection. Human neuroblastoma cells
have the advantage of being inexpensive, consistent and
reproducible neuronal cell model (34). These cells supported a
productive ZIKV replication cycle, with a similar inflammatory
profile. However, an important finding from our work is
that the ex vivo profiling of the CNS inflammation in
ZIKV-induced microcephaly infants supports our in vitro
experimental data.
As reported by others, the inflammatory response elicited by
ZIKV is strain-dependent, where African induces a much higher
inflammatory response than Asian strains (35). Additionally,
African strains are less effective in inhibiting type-I IFN responses
(36). In our model, we found a specific signature induced
by ZIKV/Brazil, a previously characterized South American
strain (26). Importantly, this virus was isolated from a highly
endemic area (northeastern Brazil), concomitantly at the peak
of microcephaly cases in 2015. Thus, we can assume that
ZIKV/Brazil represents a virus strain-specificity (same strain
circulating during the initial microcephaly outbreak). Evidently,
infection with both strains led to an inflammatory immune
response in hiNPCs, however differences in the magnitude of
inflammatory cytokines were found to be strain-specific, which
may help to explain why a higher incidence of microcephaly was
first observed in northeastern Brazil. A reasonable explanation is
that the lower magnitude of inflammation induced by the innate
immune responses may inefficiently limit viral replication, since
the reduced type-I IFN response may result in augmented higher
viral burden or chronification of the infection. Interestingly, as
reported by others, ZIKV Brazilian strains share characteristics
of viruses that do not induce a robust innate immune activation
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(37), whichmay render these strainsmore effective at establishing
a persistent infection or increased capacity to cross the placenta
and/or to invade the CNS. Here, although ZIKV RNA levels were
significantly lower in ZIKV/Cambodia compared to ZIKV/Brazil
infected hiNPCs, we observed only a slight difference in the
presence of infectious virus at 48 hpi, and thus a complete
virus growth curve would be more enlightening. Therefore,
our results contribute to a better understanding of ZIKV
immunopathological processes, and they are in agreement with
a previous report where an American strain of ZIKV results
in an enhanced viral load and a more severe microcephaly
phenotype in mice (38). Importantly, as demonstrated in an
independent study, a distinct ZIKV Brazilian strain showed a
delayed production of infectious virus in vitro. By comparing
ZIKV/Cambodia to ZIKV Brazil Fortaleza (GenBank: KX811222)
the authors found that ZIKV/Brazil reached a virus production
peak at a later time point (72 h), whereas in early times this
difference was not so evident (37).
Through the transcriptional profile analysis and multiplex
immunoassays, we identified key major cellular signaling
pathways and inflammatory markers. Transcriptomic data of
experimentally ZIKV infected cells have been generated by
several independent groups (39–41), however, given the large
variability of the cell lines employed, time of infection, virus
strains and amount of infectious particles on each approach,
combinatory analysis of such data becomes challenging. We
demonstrated that IFN-α, CXCL10, and CXCL9 levels were
significantly higher in CSF samples obtained from ZIKV-induced
microcephaly cases, compared to healthy control subjects. It is
important to note that all CSF sampling was performed right
after birth, up to a maximum of 4 weeks of life, ensuring that
the presence of soluble immune mediators is representative of
a sustained inflammatory process. High variation in expression
levels of a few cytokines (notably IL-1β and IL-1RA) was
observed, potentially demonstrating that we missed the detection
of specific perturbations as the result of a single time point
sampling (after birth). Also, several cytokines were below the
detection limit, indicating their low levels of expression in
the CSF. We could not predict exactly when the infection
occurred, which may explain some of the variations observed.
However, even though the virus was not detected in most of the
subjects analyzed, as illustrated by the large proportion of rRT-
PCR negative CSF samples, we can assume that the resulting
inflammation is persistent.
Remarkably, several different congenital infections lead to a
common clinical presentation, collectively denominated TORCH
(Toxoplasmosis, Other, Rubella, Cytomegalovirus, and Herpes)
these congenital infections also result in microcephaly and
cerebral calcifications. Overall, these pathogens are highly
neurotropic, but first, they must cross the placenta to induce
fetal damage (42). Currently, it remains unclear how ZIKV can
reach the fetal compartment, as well as the exact fetal tissues
targeted. Albeit ZIKV antigens and viral RNA were detected
almost exclusively in the brains of infants and fetuses with
microcephaly (7, 8, 43) no descriptions regarding the neural
tissue inflammation has been reported. Interestingly, Aicardi-
Goutières syndrome (AGS) resembles the clinical findings
of ZIKV-induced microcephaly. AGS patients present brain
calcifications, changes in white matter, cerebral atrophy and the
laboratory findings include increased levels of IFN-α in the CSF
(44). Mechanistically, AGS patients have been classified in the
group of type-I interferonopathies, which comprise a group of
genetic (Mendelian) disorders caused by a sustained type-I IFN
response during the embryonic development. Experimentally,
the chronic exposure of astrocytes to high levels of IFN-
α resulted in reduced cell proliferation, increase in antigen-
presenting genes and down-regulation of pro-angiogenic factors
(45). Besides, the transgenic expression of IFN-α in the CNS of
mice induces inflammation and neurodegeneration, similar to
that seen in AGS (46–48). Based on this we can assume that the
sustained levels of type-I IFN, here described, may play a role
in ZIKV-induced microcephaly contributing to the induction of
detrimental developmental effects.
Recently published reports from animal models, which
explored the effects of ZIKV during pregnancy, required the
blockade of type-I IFNs to achieve susceptible hosts (19, 49).
Thus, the absence of type-I IFN signaling in ZIKV animal
experiments lacks an important component in studies related
to ZIKV immunopathogenesis. In agreement with our data, the
induction of type-I IFN signaling, as a result of ZIKV infection
in mice, led to increased apoptosis in the placental labyrinth,
abnormal maternal-fetal barrier, and fetal hypoxia. Moreover,
type-I IFN treatment of human midgestation villous explants
led to abnormal villous structures, which are strongly associated
with growth restriction and spontaneous abortions (50). Albeit
of great relevance, the authors explored the effects of type-I IFNs
exclusively on the developing placenta. Here, we propose that
type-I IFNs may play an important role in developmental defects
caused by ZIKV, specifically in the context of brain damage, as a
result of chronic local inflammation.
As reported, ZIKV non-structural proteins are effective in
inhibiting type-I IFN, which favors virus replication andmay lead
to viral persistence in different body compartments (51–53). In
fact, recent reports describe ZIKV persistence in infants (54, 55)
and adults (56). Here, we hypothesize that peripheral type-I IFN
inhibition is an essential step that facilitates CNS invasion. Once
in the CNS, the virus induces a sustained, suboptimal type-I
IFN response that leads to extensive neuroinflammation and
tissue injury. Interestingly, activation of type-I IFN signaling
in brain endothelial and epithelial barriers results in CXCL10
release into the brain parenchyma and this signaling cascade
was recently correlated to “sickness behavior,” a common set of
symptoms due to viral infections (57). Of note, CXCL10 and
CXCL9 can be induced by both, type-II (IFN-γ) and type-I
IFNs (58). Increased levels of IFN-α and CXCL10 in the CSF
of AGS patients were already documented, and these findings
were associated with the absence of IFN-γ (59). Mechanistically,
CXCL9 and CXCL10 bind to CXCR3, a receptor primarily
expressed on T cells and NK cells (60) also found in NPCs
(61). Among other effects, CXCL10 treated neurons developed
increased membrane permeability, which was followed by
caspase-3 dependent apoptosis (62). In fact, ZIKV infection
leads to extensive caspase-3 activation in different animal and
in vitro models (19, 29, 63, 64). This correlation becomes
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more apparent considering that IFN-α/β treatment leads to
enhanced calcification of cultured human vascular smooth
muscle cells (65), indicating that IFN-α promotes the generation
of calcium deposits and supports the proposition that IFN-α
acts directly on ZIKV-induced microcephaly calcifications, a
frequently reported clinical finding. Thus, we suggest that in
the CNS, induction of IFN-α by ZIKV infection acts to further
up-regulate the local chemokine response and consequently,
apoptosis. On the other hand, direct IFN-independent induction
of CXCL10 has been documented for different RNA viruses (66–
68). Interestingly, CXCL10 elicits apoptosis in fetal neurons,
dependent on intracellular Ca(2+) increase and caspase-3
activation (69). Based on this, we propose a model in which
these inflammatory mediators act synergistically contributing
to most of the alterations observed in microcephaly cases.
To our knowledge, we are the first to demonstrate a more
detailed neuroinflammation profile from human cases of ZIKV-
induced microcephaly. Collectively, our data corroborate other
independent findings that implicate type-I IFNs as a potential
modulating factor in ZIKV-associated pregnancy complications.
DATA AVAILABILITY
RNA-Seq data are available at NCBI BioProject under accession
number PRJNA551246. Data supporting this study can be found
at Supplementary Files. A complete description of methods can
be requested from the corresponding author, further information
supporting this study can also be made available.
AUTHOR CONTRIBUTIONS
ML and RC performed the sample processing, Luminex assays,
and analysis. ML, EA, RA, PF, PC, and CA-S contributed
to the sample classification and laboratory diagnosis. LM
performed the SH-SY5Y cells infection experiments, FACS, qRT-
PCR analysis, and Luminex assays. MD, LD’A, KC, and JW
performed the hiNPCs infection experiments and RNA-Seq
assay. AR performed the RNA-Seq and transcriptomics analysis.
PC performed the virus quantification assay. AL-A, MG, and RF
performed the statistical analysis of cytokines and chemokines
profile in human samples. EM, AL-A, RF, CD, AK, VN, and
MB-N contributed to the data interpretation and discussion.
RF conceived the study, supervised the study, and wrote the
manuscript. All authors discussed the results and contributed to
the final manuscript.
FUNDING
The research leading to these results received funding
from the Fundação de Amparo à Ciência e Tecnologia
de Pernambuco/FACEPE, grant agreement nos. APQ-
0055.2.11/16 and APQ-0044.2.11/16, and Conselho Nacional
de Desenvolvimento Científico e Tecnológico/CNPq
grant agreement 439975/2016-6 under RF coordination
and responsibility. UK Medical Research Council Grants
MC_UU_12014/8 and MR/N017552/1 under AK’s coordination.
VN received grant support from the Stanley Medical Research
Institute (07R-1712), National Institutes of Health (MH63480
and D43 TW009114) and Cura Zika—University of Pittsburgh.
The funders had no role in study design, data collection, and
analysis, decision to publish, or preparation of the manuscript.
ACKNOWLEDGMENTS
The authors thank the Fiocruz Luminex Platform (Subunidade
Luminex-RPT03C Rede de Plataformas PDTIS, FIOCRUZ/RJ)
for the use of its Luminex facilities. We also thanks Dr. Akiko
Iwasaki from Howard Hughes Medical Institute, Yale School of
Medicine, for her generosity on cytokines multiplex assays.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fimmu.
2019.01928/full#supplementary-material
REFERENCES
1. Miranda-Filho D de B, Martelli CMT, Ximenes RA de A, Araújo TVB,
Rocha MAW, Ramos RCF, et al. Initial description of the presumed
congenital Zika syndrome. Am J Public Health. (2016) 106:598–600.
doi: 10.2105/AJPH.2016.303115
2. Moore CA, Staples JE, Dobyns WB, Pessoa A, Ventura CV, Fonseca
EB da, et al. Characterizing the pattern of anomalies in congenital
Zika syndrome for pediatric clinicians. JAMA Pediatr. (2017) 171:288–95.
doi: 10.1001/jamapediatrics.2016.3982
3. de Araújo TVB, Rodrigues LC, de Alencar Ximenes RA, de Barros Miranda-
Filho D, Montarroyos UR, de Melo APL, et al. Association between
Zika virus infection and microcephaly in Brazil, January to May, 2016:
preliminary report of a case-control study. Lancet Infect Dis. (2016) 16:1356–
63. doi: 10.1016/S1473-3099(16)30318-8
4. de Araújo TVB, Ximenes RA de A, Miranda-Filho D de B, Souza
WV, Montarroyos UR, de Melo APL, et al. Association between
microcephaly, Zika virus infection, and other risk factors in Brazil:
final report of a case-control study. Lancet Infect Dis. (2018) 18:328–36.
doi: 10.1016/S1473-3099(17)30727-2
5. Faria NR, Azevedo RDSDS, KraemerMUG, Souza R, CunhaMS, Hill SC, et al.
Zika virus in the Americas: early epidemiological and genetic findings. Science.
(2016) 352:345–9. doi: 10.1126/science.aaf5036
6. Calvet G, Aguiar RS, Melo ASO, Sampaio SA, de Filippis I, Fabri A, et al.
Detection and sequencing of Zika virus from amniotic fluid of fetuses with
microcephaly in Brazil: a case study. Lancet Infect Dis. (2016) 16:653–60.
doi: 10.1016/S1473-3099(16)00095-5
7. Mlakar J, Korva M, Tul N, Popovic´ M, Poljšak-Prijatelj M, Mraz J, et al.
Zika virus associated with microcephaly. New Engl J Med. (2016) 374:951–8.
doi: 10.1056/NEJMoa1600651
8. Driggers RW, Ho C-Y, Korhonen EM, Kuivanen S, Jääskeläinen AJ,
Smura T, et al. Zika virus infection with prolonged maternal viremia
and fetal brain abnormalities. New Engl J Med. (2016) 374:2142–51.
doi: 10.1056/NEJMoa1601824
9. Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. New Engl J
Med. (2016) 374:1552–63. doi: 10.1056/NEJMra1602113
Frontiers in Immunology | www.frontiersin.org 12 August 2019 | Volume 10 | Article 1928
Lima et al. Immune Profiles of Zika Microcephaly
10. Paz-Bailey G, Rosenberg ES, Doyle K, Munoz-Jordan J, Santiago GA, Klein L,
et al. Persistence of Zika virus in body fluids–final report. New Engl J Med.
(2018) 379:1234–43. doi: 10.1056/NEJMoa1613108
11. Lazear HM, Stringer EM, de Silva AM. The emerging Zika virus
epidemic in the Americas: research priorities. JAMA. (2016) 315:1945–6.
doi: 10.1001/jama.2016.2899
12. Cordeiro MT, Pena LJ, Brito CA, Gil LH, Marques ET. Positive IgM for Zika
virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil.
Lancet. (2016) 387:1811–2. doi: 10.1016/S0140-6736(16)30253-7
13. Liang Q, Luo Z, Zeng J, Chen W, Foo S-S, Lee S-A, et al. Zika virus NS4A
and NS4B proteins deregulate Akt-mTOR signaling in human fetal neural
stem cells to inhibit neurogenesis and induce autophagy.Cell Stem Cell. (2016)
19:663–71. doi: 10.1016/j.stem.2016.07.019
14. Li C, Xu D, Ye Q, Hong S, Jiang Y, Liu X, et al. Zika virus disrupts neural
progenitor development and leads to microcephaly in mice. Cell Stem Cell.
(2016) 19:672. doi: 10.1016/j.stem.2016.10.017
15. Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P, Delvecchio
R, et al. Zika virus impairs growth in human neurospheres and brain
organoids. Science. (2016) 352:816–8. doi: 10.7287/peerj.preprints.1817v3
16. Tang H, Hammack C, Ogden SC, Wen Z, Qian X, Li Y, et al. Zika virus infects
human cortical neural progenitors and attenuates their growth. Cell Stem Cell.
(2016) 18:587–90. doi: 10.1016/j.stem.2016.02.016
17. Cugola FR, Fernandes IR, Russo FB, Freitas BC, Dias JLM,Guimarães KP, et al.
The Brazilian Zika virus strain causes birth defects in experimental models.
Nature. (2016) 534:267–71. doi: 10.1038/nature18296
18. Lazear HM, Govero J, Smith AM, Platt DJ, Fernandez E, Miner JJ, et al. A
mouse model of Zika virus pathogenesis. Cell Host Microbe. (2016) 19:720–30.
doi: 10.1016/j.chom.2016.03.010
19. Miner JJ, Cao B, Govero J, Smith AM, Fernandez E, Cabrera OH, et al. Zika
virus infection during pregnancy in mice causes placental damage and fetal
demise. Cell. (2016) 165:1081–91. doi: 10.1016/j.cell.2016.05.008
20. Brown JA, Singh G, Acklin JA, Lee S, Duehr JE, Chokola AN, et al. Dengue
Virus immunity increases Zika virus-induced damage during pregnancy.
Immunity. (2019) 50:751–62.e5. doi: 10.1057/978-1-137-55247-1
21. Devakumar D, Bamford A, Ferreira MU, Broad J, Rosch RE, Groce N,
et al. Infectious causes of microcephaly: epidemiology, pathogenesis,
diagnosis, and management. Lancet Infect Dis. (2018) 18:e1–3.
doi: 10.1016/S1473-3099(17)30398-5
22. Hazin AN, Poretti A, Di Cavalcanti Souza Cruz D, Tenorio M, van
der Linden A, Pena LJ, et al. Computed tomographic findings in
microcephaly associated with Zika Virus. New Engl J Med. (2016) 374:2193–5.
doi: 10.1056/NEJMc1603617
23. Tappe D, Pérez-Girón JV, Zammarchi L, Rissland J, Ferreira DF, Jaenisch
T, et al. Cytokine kinetics of Zika virus-infected patients from acute
to reconvalescent phase. Med Microbiol Immunol. (2016) 205:269–73.
doi: 10.1007/s00430-015-0445-7
24. Ornelas AMM, Pezzuto P, Silveira PP, Melo FO, Ferreira TA, Oliveira-
Szejnfeld PS, et al. Immune activation in amniotic fluid from
Zika virus-associated microcephaly. Ann Neurol. (2017) 81:152–6.
doi: 10.1002/ana.24839
25. Naveca FG, Pontes GS, Chang AY, Silva GAVD, Nascimento VAD, Monteiro
DCDS, et al. Analysis of the immunological biomarker profile during acute
Zika virus infection reveals the overexpression of CXCL10, a chemokine
linked to neuronal damage. Memorias do Inst Oswaldo Cruz. (2018)
113:e170542. doi: 10.1590/0074-02760170542
26. Donald CL, Brennan B, Cumberworth SL, Rezelj VV, Clark JJ, Cordeiro
MT, et al. Full genome sequence and sfRNA interferon antagonist activity of
Zika virus from Recife, Brazil. PLoS Neglected Trop Dis. (2016) 10:e0005048.
doi: 10.1371/journal.pntd.0005048
27. Castro MAA, Filho JLR, Dalmolin RJS, Sinigaglia M, Moreira JCF,
Mombach JCM, et al. ViaComplex: software for landscape analysis of gene
expression networks in genomic context. Bioinforma. (2009) 25:1468–9.
doi: 10.1093/bioinformatics/btp246
28. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ,
et al. Genetic and serologic properties of Zika virus associated with an
epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. (2008) 14:1232–9.
doi: 10.3201/eid1408.080287
29. Souza BSF, Sampaio GLA, Pereira CS, Campos GS, Sardi SI, Freitas LAR,
et al. Zika virus infection induces mitosis abnormalities and apoptotic
cell death of human neural progenitor cells. Sci Rep. (2016) 6:39775.
doi: 10.1038/srep39775
30. Li C, Xu D, Ye Q, Hong S, Jiang Y, Liu X, et al. Zika virus disrupts neural
progenitor development and leads to microcephaly in mice. Cell Stem Cell.
(2016) 19:120–6. doi: 10.1016/j.stem.2016.04.017
31. Gabriel E, Ramani A, Karow U, Gottardo M, Natarajan K, Gooi LM,
et al. Recent Zika virus isolates induce premature differentiation of neural
progenitors in human brain organoids. Cell Stem Cell. (2017) 20:397–406.e5.
doi: 10.1016/j.stem.2016.12.005
32. Hanners NW, Eitson JL, Usui N, Richardson RB, Wexler EM, Konopka G,
et al. Western Zika virus in human fetal neural progenitors persists long term
with partial cytopathic and limited immunogenic effects. Cell Rep. (2016)
15:2315–22. doi: 10.1016/j.celrep.2016.05.075
33. Hu B-Y, Weick JP, Yu J, Ma L-X, Zhang X-Q, Thomson JA, et al.
Neural differentiation of human induced pluripotent stem cells follows
developmental principles but with variable potency. Proc Natl Acad Sci USA.
(2010) 107:4335–40. doi: 10.1073/pnas.0910012107
34. ShipleyMM,Mangold CA, SzparaML. Differentiation of the SH-SY5Y human
neuroblastoma cell line. J Vis Exp. (2016) 2016:53193. doi: 10.3791/53193
35. Tripathi S, Balasubramaniam VRMT, Brown JA, Mena I, Grant A, Bardina
SV, et al. A novel Zika virus mouse model reveals strain specific differences in
virus pathogenesis and host inflammatory immune responses. PLoS Pathog.
(2017) 13:e1006258. doi: 10.1371/journal.ppat.1006258
36. Foo S-S, Chen W, Chan Y, Bowman JW, Chang L-C, Choi Y, et al. Asian
Zika virus strains target CD14 blood monocytes and induce M2-skewed
immunosuppression during pregnancy. Nat Microbiol. (2017) 2:1558–70.
doi: 10.1038/s41564-017-0016-3
37. Esser-Nobis K, Aarreberg LD, Roby JA, Fairgrieve MR, Green R, Gale M Jr.
Comparative analysis of African and Asian lineage-derived Zika virus strains
reveals differences in activation of and sensitivity to antiviral innate immunity.
J Virol. (2019) 93:1–8. doi: 10.1128/JVI.00640-19
38. Zhang F, Wang H-J, Wang Q, Liu Z-Y, Yuan L, Huang X-Y, et al.
American strain of Zika virus causes more severe microcephaly than
an old Asian strain in neonatal mice. EBioMedicine. (2017) 25:95–105.
doi: 10.1016/j.ebiom.2017.10.019
39. Brahma R, Gurumayum S, Naorem LD,MuthaiyanM, Gopal J, Venkatesan A.
Identification of hub genes and pathways in Zika virus infection using RNA-
seq data: a network-based computational approach. Viral Immunol. (2018)
31:321–32. doi: 10.1089/vim.2017.0116
40. Singh PK, Khatri I, Jha A, Pretto CD, Spindler KR, Arumugaswami V, et al.
Determination of system level alterations in host transcriptome due to Zika
virus (ZIKV) infection in retinal pigment epithelium. Sci Rep. (2018) 8:11209.
doi: 10.1038/s41598-018-29329-2
41. Zanini F, Pu S-Y, Bekerman E, Einav S, Quake SR. Single-cell
transcriptional dynamics of flavivirus infection. eLife. (2018) 7:e32942.
doi: 10.7554/eLife.32942
42. Coyne CB, Lazear HM. Zika virus–reigniting the TORCH. Nat Rev Microbiol.
(2016) 14:707–15. doi: 10.1038/nrmicro.2016.125
43. Martines RB, Bhatnagar J, de Oliveira Ramos AM, Davi HPF, Iglezias SD,
Kanamura CT, et al. Pathology of congenital Zika syndrome in Brazil:
a case series. Lancet. (2016) 388:898–904. doi: 10.1016/S0140-6736(16)3
0883-2
44. Goutières F, Aicardi J, Barth PG, Lebon P. Aicardi-Goutières syndrome: An
update and results of interferon-alpha studies. Ann Neurol. (1998) 44:900–7.
doi: 10.1002/ana.410440608
45. Cuadrado E, Jansen MH, Anink J, De Filippis L, Vescovi AL, Watts C, et al.
Chronic exposure of astrocytes to interferon-α reveals molecular changes
related to Aicardi-Goutieres syndrome. Brain : J Neurol. (2013) 136:245–58.
doi: 10.1093/brain/aws321
46. Akwa Y, Hassett DE, Eloranta ML, Sandberg K, Masliah E, Powell H, et al.
Transgenic expression of IFN-alpha in the central nervous system of mice
protects against lethal neurotropic viral infection but induces inflammation
and neurodegeneration. J Immunol. (1998) 161:5016–26.
47. Campbell IL, Krucker T, Steffensen S, Akwa Y, Powell HC, Lane T,
et al. Structural and functional neuropathology in transgenic mice
Frontiers in Immunology | www.frontiersin.org 13 August 2019 | Volume 10 | Article 1928
Lima et al. Immune Profiles of Zika Microcephaly
with CNS expression of IFN-alpha. Brain Res. (1999) 835:46–61.
doi: 10.1016/S0006-8993(99)01328-1
48. Crow YJ. Type I interferonopathies: a novel set of inborn
errors of immunity. Ann New York Acad Sci. (2011) 1238:91–8.
doi: 10.1111/j.1749-6632.2011.06220.x
49. Yockey LJ, Varela L, Rakib T, Khoury-Hanold W, Fink SL, Stutz B, et al.
Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection.
Cell. (2016) 166:1247–56.e4. doi: 10.1016/j.cell.2016.08.004
50. Yockey LJ, Jurado KA, Arora N, Millet A, Rakib T, Milano KM, et al. Type
I interferons instigate fetal demise after Zika virus infection. Sci Immunol.
(2018) 3:eaao1680. doi: 10.1126/sciimmunol.aao1680
51. Grant A, Ponia SS, Tripathi S, Balasubramaniam V, Miorin L, Sourisseau M,
et al. Zika virus targets human STAT2 to inhibit type I interferon signaling.
Cell Host Microbe. (2016) 19:882–90. doi: 10.1016/j.chom.2016.05.009
52. Bowen JR, Quicke KM, Maddur MS, O’Neal JT, McDonald CE, Fedorova
NB, et al. Zika virus antagonizes type I interferon responses during
infection of human dendritic cells. PLoS Pathog. (2017) 13:e1006164.
doi: 10.1371/journal.ppat.1006164
53. Yuan L, Huang X-Y, Liu Z-Y, Zhang F, Zhu X-L, Yu J-Y, et al. A singlemutation
in the prM protein of Zika virus contributes to fetal microcephaly. Science.
(2017) 358:933–6. doi: 10.1126/science.aam7120
54. Chimelli L, Moura Pone S, Avvad-Portari E, Farias Meira Vasconcelos Z,
Araújo Zin A, Prado Cunha D, et al. Persistence of Zika virus after birth:
clinical, virological, neuroimaging, and neuropathological documentation in
a 5-month infant with congenital Zika syndrome. J Neuropathol Exp Neurol.
(2018) 77:193–8. doi: 10.1093/jnen/nlx116
55. Brito CAA, Henriques-Souza A, Soares CRP, Castanha PMS, Machado LC,
Pereira MR, et al. Persistent detection of Zika virus RNA from an infant
with severe microcephaly–a case report. BMC Infect Dis. (2018) 18:388.
doi: 10.1186/s12879-018-3313-4
56. Paz-Bailey G, Rosenberg ES, Sharp TM. Persistence of Zika virus
in body fluids–final report. New Engl J Med. (2019) 380:198–9.
doi: 10.1056/NEJMc1814416
57. Blank T, Detje CN, Spieß A, Hagemeyer N, Brendecke SM, Wolfart J, et al.
Brain endothelial- and epithelial-specific interferon receptor chain 1 drives
virus-induced sickness behavior and cognitive impairment. Immunity. (2016)
44:901–2. doi: 10.1016/j.immuni.2016.04.005
58. Padovan E, Spagnoli GC, Ferrantini M, Heberer M. IFN-alpha2a induces IP-
10/CXCL10 andMIG/CXCL9 production in monocyte-derived dendritic cells
and enhances their capacity to attract and stimulate CD8+ effector T cells. J
Leukoc Biol. (2002) 71:669–76. doi: 10.1189/jlb.71.4.669
59. van Heteren JT, Rozenberg F, Aronica E, Troost D, Lebon P, Kuijpers TW.
Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in
Aicardi-Goutières syndrome. Glia. (2008) 56:568–78. doi: 10.1002/glia.20639
60. Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative
and antagonistic functions. Immunol Cell Biol. (2011) 89:207–15.
doi: 10.1038/icb.2010.158
61. Tran PB, Banisadr G, Ren D, Chenn A, Miller RJ. Chemokine
receptor expression by neural progenitor cells in neurogenic regionsof
mouse brain. J Comp Neurol. (2007) 500:1007–33. doi: 10.1002/cne.
21229
62. Sui Y, Potula R, Dhillon N, Pinson D, Li S, Nath A, et al. Neuronal
apoptosis is mediated by CXCL10 overexpression in simian human
immunodeficiency virus encephalitis. Am J Pathol. (2004) 164:1557–66.
doi: 10.1016/S0002-9440(10)63714-5
63. Huang W-C, Abraham R, Shim B-S, Choe H, Page DT. Zika virus infection
during the period of maximal brain growth causes microcephaly and
corticospinal neuron apoptosis in wild type mice. Sci Rep. (2016) 6:34793.
doi: 10.1038/srep34793
64. Retallack H, Di Lullo E, Arias C, Knopp KA, Laurie MT, Sandoval-Espinosa
C, et al. Zika virus cell tropism in the developing human brain and
inhibition by azithromycin. Proc Natl Acad Sci USA. (2016) 113:14408–13.
doi: 10.1073/pnas.1618029113
65. Klok MD, Bakels HS, Postma NL, van Spaendonk RML, van der Knaap
MS, Bugiani M. Interferon-α and the calcifying microangiopathy in
Aicardi-Goutières syndrome. Ann Clin Transl Neurol. (2015) 2:774–9.
doi: 10.1002/acn3.213
66. Asensio VC, Maier J, Milner R, Boztug K, Kincaid C, Moulard
M, et al. Interferon-independent, human immunodeficiency virus
type 1 gp120-mediated induction of CXCL10/IP-10 gene expression
by astrocytes in vivo and in vitro. J Virol. (2001) 75:7067–77.
doi: 10.1128/JVI.75.15.7067-7077.2001
67. Brownell J, Bruckner J, Wagoner J, Thomas E, Loo Y-M, Gale M, et al. Direct,
interferon-independent activation of the CXCL10 promoter by NF-κB and
interferon regulatory factor 3 during hepatitis C virus infection. J Virol. (2014)
88:1582–90. doi: 10.1128/JVI.02007-13
68. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA,
et al. Neuronal CXCL10 directs CD8+ T-cell recruitment and
control of West Nile virus encephalitis. J Virol. (2005) 79:11457–66.
doi: 10.1128/JVI.79.17.11457-11466.2005
69. Sui Y, Stehno-Bittel L, Li S, Loganathan R, Dhillon NK, Pinson D, et al.
CXCL10-induced cell death in neurons: role of calcium dysregulation.
Eur J Neurosci. (2006) 23:957–64. doi: 10.1111/j.1460-9568.2006.
04631.x
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Lima, Mendonça, Rezende, Carrera, Aníbal-Silva, Demers,
D’Aiuto, Wood, Chowdari, Griffiths, Lucena-Araujo, Barral-Netto, Azevedo, Alves,
Farias, Marques, Castanha, Donald, Kohl, Nimgaonkar and Franca. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Immunology | www.frontiersin.org 14 August 2019 | Volume 10 | Article 1928
